Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02005263 · ClinicalTrials.gov registry record · NA

Hysteroscopic Assessment of Fallopian Tubal Patency

A NA study of Infertility and Menorrhagia, sponsored by University of Mississippi Medical Center.

Completed
Registry status
NA
Development phase
621
Enrollment target
1
Study location

NCT02005263: Completed NA study of Infertility and Menorrhagia, sponsored by University of Mississippi Medical Center.

NCT02005263 is a NA study of Infertility and Menorrhagia that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 621 participants, below the 7,581-participant average among 74 other Infertility trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02005263, a NA study of Infertility and Menorrhagia, has completed, sponsored by University of Mississippi Medical Center.

COMPLETED
Registry status
NA
Development phase
621 participants
Enrollment target
1
Study location

Study Summary

Disease of the fallopian tubes is one of the most common reasons for infertility. The most common test, a hysterosalpingogram, tends to be painful,inconvenient, and frequently misses concurrent uterine disease. We propose using a less painful technique (through modified office hysteroscopy) for tubal assessment that can be performed in the office rather than hospital radiology and that uses gold standard technology for identifying coexisting uterine conditions.

Primary Outcome

Patients undergoing the procedure will be informed based on the findings as to whether or not it is believed that their Fallopian tubes are patent

Conditions Studied

Interventions

  • PROCEDURE Salpingography

Study Locations (1)

Mississippi

  • University of Mississippi Medical Center - Jackson

Trial Details

FieldValue
Enrollment Target 621 participants
Start Date 2013-12
Est. Completion 2017-11-06
Phase NA

What the finished NCT02005263 record still lists

NCT02005263 is an interventional study that assigns participants to a tested intervention. The registered 621 participants enrollment target is mid-sized for trials with a published cap, below the 7,581-participant average among 74 other Infertility trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Salpingography is the first listed.

NCT02005263 reports a single indexed study location in Mississippi.

Frequently Asked Questions

What is clinical trial NCT02005263 about?

NCT02005263 is a clinical study titled "Hysteroscopic Assessment of Fallopian Tubal Patency". Disease of the fallopian tubes is one of the most common reasons for infertility. The most common test, a hysterosalpingogram, tends to be painful,inconvenient, and frequently misses concurrent uterine disease. We propose using a less painful technique (through modified office hysteroscopy) for tuba...

What is the current status of trial NCT02005263?

This trial is currently completed. It is a NA study. The enrollment target is 621 participants. The study started on 2013-12. Estimated completion is 2017-11-06.

What conditions does trial NCT02005263 study?

This clinical trial studies the following conditions: Infertility, Menorrhagia.

What interventions are being tested in trial NCT02005263?

The interventions under investigation include: Salpingography (PROCEDURE).

Who is sponsoring clinical trial NCT02005263?

This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02005263 being conducted?

This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02005263's enrollment target sits among peer trials

621 21st of 74 higher than 54 of 74 other Infertility trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06712355 · 621 participants · Phase 3

    Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • NCT02282969 · 620 participants

    PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

  • NCT02838836 · 620 participants

    Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

  • NCT05538910 · 620 participants · NA

    Defining Neurobiological Links Between Substance Use and Mental Illness

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02005263, the US trial registry maintained by the National Library of Medicine. NCT02005263 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.